Novo CEO pressed by Senate to cut price ranges of weight problems, diabetic issues medications CEO Lars Fruergaard Jørgensen instructed lawmakers the company would contemplate new talks with insurers concerning the list charges of Wegovy and copyright when they pledge to maintain the medicines on their formularies. Previously this summertime, https://reidbzxwu.onzeblog.com/30656314/what-does-healthcare-news-mean